Intellectual Property

We license the intellectual property necessary to conduct our business from Washington University of St. Louis pursuant to a License Agreement. The License Agreement is exclusive for human therapeutics, with the right to sub-license, for all therapeutic proteins and peptides, of natural or non-natural sequence, other than four endocrine proteins - LH, FSH, TSH and hCG, previously licensed to Merck & Co., a leading pharmaceutical company. In addition, we have been issued by the U.S. Patent Office two new proprietary patents covering our long-acting hGH and EPO drug candidates.